Recombinant Human BPHL Protein (Baculovirus)，His & Myc

BPHL (Butyrylcholinesterase-Like Protein) is a member of the serine hydrolase family, which plays a crucial role in various physiological processes, including lipid metabolism and neurotransmission. Its research background is rooted in the increasing interest in enzyme functions and their implications in health and disease. Studies have shown that BPHL may be involved in the hydrolysis of bioactive compounds and could influence drug metabolism and clearance in the body. Given its lack of thorough characterization compared to other members of its family, there is a growing impetus to explore its potential as a biomarker for certain diseases and as a target in drug design and therapeutic applications. Moreover, BPHL's role in regulating cholinergic and neuroprotective functions highlights its potential relevance in neurodegenerative disorders, such as Alzheimer's disease. Investigating BPHL's structure, function, and interaction with various substrates may provide deeper insights into its biological roles and pave the way for novel therapeutic strategies in treating diseases linked to cholinergic dysfunction and metabolic disorders. As recombinant protein technology advances, producing BPHL in a laboratory setting promises to facilitate these studies, allowing for a comprehensive analysis of its enzymatic properties, structure-function relationships, and potential clinical applications. Thus, BPHL represents a promising frontier in enzymology and biomedical research, with implications that extend across multiple areas of health science.